Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Madrid
Clinical trial register · Spain

Clinical Trials in Madrid, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Madrid 26 Barcelona 21 Valencia 16 Seville 15 Salamanca 9
Narrow the registerReset
Recruitment status
Phase
Site location
Madrid26 Barcelona21 Valencia16 Seville15 Salamanca9
All 38 locations
Target enrolment
to

Trials with a site in Madrid

26 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
Takeda
Phase 3
324
Badalona, L'Hospitalet de Llobregat, Las Palmas de Gran Canaria, Málaga, Barcelona, Madrid, Salamanca, Valencia
2026-09-10
Recruiting
Takeda
Phase 2
92
Barcelona, Madrid
2026-06-04
Recruiting
Takeda
Phase 3
300
L'Hospitalet de Llobregat, Seville, Barcelona, Madrid, Málaga, Salamanca, Valencia
2026-05-21
Active, closed
A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy
NCT07363720Narcolepsy Type 1 (NT1), Narcolepsy With Cataplexy
Takeda
Phase 3
98
Vitoria-Gasteiz, Alzira, Barcelona, Madrid
2026-01-29
Recruiting
Takeda
Phase 3
183
Madrid, Marbella, Palma de Mallorca, Salamanca, Valencia
2026-01-14
Recruiting
Takeda
Phase 3
110
Santiago de Compostela, Barcelona, Madrid
2025-12-04
Active, closed
Epidemiology of Narcolepsy Type 1 and Type 2 in Spain
NCT07299097Narcolepsy Type 1, Narcolepsy Type 2
Takeda
Observational
402
Castellon, Pamplona, Alzira, Barcelona, Granada, Madrid, Seville, Vitoria-Gasteiz
2025-12-02
Recruiting
Takeda
Observational
10
L'Hospitalet de Llobregat, Barakaldo, Barcelona, Córdoba, Madrid, Málaga, Seville
2025-11-03
Recruiting
Takeda
Phase 2
200
Las Palmas de Gran Canaria, Córdoba, Madrid, Valencia
2025-11-03
Recruiting
Takeda
Phase 3
70
Ferrol, Madrid, Seville, Valencia
2025-10-27
Recruiting
Takeda
Phase 3
150
Alcorcón, Madrid, Burgos, Salamanca, Seville
2025-08-14
Recruiting
Takeda
Phase 3
347
Badalona, Barakaldo, Pamplona, Barcelona, Madrid, Seville
2025-07-15
Recruiting
Takeda
Phase 2
88
Madrid
2025-05-06
Recruiting
Takeda
Phase 3
225
Salamanca, Barcelona, L'Hospitalet de Llobregat, Madrid, Valencia
2025-05-06
Recruiting
Takeda
Phase 3
600
Vitoria-Gasteiz, Santander, Alcobendas, Madrid, Santa Cruz de Tenerife, Seville
2025-03-10
Recruiting
Takeda
Phase 3
171
Alcorcón, Madrid, Salamanca, Seville
2025-02-27
Recruiting
Takeda
Phase 2
96
Vitoria-Gasteiz, Madrid
2025-02-07
Recruiting
Takeda
Phase 3
70
Ferrol, Madrid, Seville, Valencia
2025-01-22
Recruiting
Takeda
Phase 3
396
Madrid, Palma, Pamplona, Santiago de Compostela, Valencia
2025-01-02
Recruiting
Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency
NCT05879757Multiple Myeloma, Secondary Immunodeficiency (SID)
Takeda
Observational
75
Madrid, Palma
2023-10-17
Recruiting
Takeda
Phase 3
240
Sagunto, Barcelona, Madrid, Málaga, Seville
2023-05-16
Recruiting
Takeda
Phase 2/3
500
Vitoria-Gasteiz, Castellon, Alzira, Barcelona, Madrid
2023-04-05
Recruiting
Takeda
Phase 3
120
Esplugues de Llobregat, Sagunto, Madrid, Málaga, Seville
2022-02-10
Recruiting
Takeda
Phase 2
135
Badalona, Barcelona, Madrid, Salamanca, Valencia, Zaragoza
2021-12-16
Active, closed
Takeda
Phase 3
354
L'Hospitalet de Llobregat, A Coruña, Alicante, Barcelona, Córdoba, Madrid, Valencia
2020-01-10
Rows per page Showing 1–26 of 26
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 October 2026. https://priyalifescience.com/clinical-trials-spain/city/madrid

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 26 of those studies with a site in Madrid that also match the filters currently applied.

How many clinical trials are recruiting in Madrid?

23 of the 26 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 3 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Madrid), 26 studies
PhaseStudiesRecruitingShare
Phase 3171565.4%
Phase 25519.2%
Observational3211.5%
Phase 2/3113.8%

Most active sponsors

Lead sponsors with the most studies (Madrid)
Lead sponsorStudiesRecruiting
Takeda2623
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.